Page last updated: 2024-11-06

lysergic acid diethylamide and Neoplasm Metastasis

lysergic acid diethylamide has been researched along with Neoplasm Metastasis in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RYSANEK, K1
VITEK, V1
Pahnke, WN1
Kurland, AA1
Unger, S1
Savage, C1
Grof, S1

Other Studies

2 other studies available for lysergic acid diethylamide and Neoplasm Metastasis

ArticleYear
COMPARATIVE STUDY OF ANTISEROTONIN EFFECTS OF LYSENYL AND DESERIL.
    Gastroenterologia, 1964, Volume: 102

    Topics: Absorption; Biomedical Research; Carcinoid Tumor; Defecation; Diarrhea; Drug Therapy; Indoleacetic A

1964
The experimental use of psychedelic (LSD) psychotherapy.
    JAMA, 1970, Jun-15, Volume: 212, Issue:11

    Topics: Alcoholism; Breast Neoplasms; Chromosome Aberrations; Depression; Female; Humans; Lysergic Acid Diet

1970